The Diligence Checklist: 12 Questions to Ask Before Signing a Telehealth Fulfillment Platform

Before signing a telehealth fulfillment platform, get written answers to twelve questions across six areas: who holds your patient data and can you export it, who pays whom and how fees are structured, what artifact proves a provider approved each order, whether funds can be held, how orders route across pharmacies, and what happens on exit. Any question a vendor will not answer in writing is your answer.

Most telehealth operators run diligence backwards. They evaluate a platform on the demo — the polished intake flow, the clean dashboard, the promise of "launch in two weeks" — and sign before asking the questions that actually determine whether the business is theirs or the vendor's. Then, eighteen months in, they discover the patient list is not exportable, the fees scale with revenue in a way that worries their attorney, and leaving means starting over.

This is the checklist that prevents that. Twelve questions, grouped into six areas. Each one maps to an answer a platform should be able to give you in writing. The point is not to catch anyone out — good infrastructure partners answer all of these readily. The point is that the questions a vendor dodges tell you exactly where the risk lives.

---

What Should I Ask About Data Ownership and Export?

Ask two questions: do I own my patient and order data as the system of record, and can I export all of it — including history — in a structured, usable format, at any time, without penalty? Data export is the master question. It determines whether you can ever leave, which determines whether you have leverage over everything else.

Your patient list, order history, provider records, and clinical documentation are the business. If they live inside a platform you cannot extract them from, you do not own a telehealth company — you rent a seat in someone else's. The HHS Office for Civil Rights enforces a patient's HIPAA Right of Access to their own records, but that is a patient right, not an operator's guarantee that a vendor will hand you a clean database on the way out.

Question 1 — Ownership: Am I the designated system of record for patient and order data, or is the platform? Get the answer named in the contract.

Question 2 — Export: Can I export all patient records, order history, and clinical documentation in a structured format (CSV, JSON, HL7/FHIR) on demand, at no charge, including after termination?

If a platform hesitates on either, the switching cost is being built into your business by design. We cover the mechanics of this in depth in telehealth data portability and why the system-of-record question is the one that compounds in owning your patient data as the system of record.

---

What Should I Ask About Fees and Who Pays Whom?

Ask how fees are calculated and who pays them. This is a compliance question as much as a pricing one. Fees tied to prescription value or volume, or funded by a spread on the drug, invite federal fraud-and-abuse scrutiny. Flat, value-blind software fees paid by the clinic for a defined service are structurally easier to defend.

The federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b) and the Eliminating Kickbacks in Recovery Act (EKRA, 18 U.S.C. § 220) both scrutinize payments tied to healthcare referrals or the value of what is dispensed. You inherit the structure of however your platform charges. A "free" platform that funds itself by marking up the medication is not free — it is taking a spread you cannot see, on a basis your counsel may not like.

Question 3 — Basis: Is the fee a flat subscription and/or a fixed per-order amount, or does it scale with the price or value of the prescription?

Question 4 — Direction: Who pays the platform — the clinic, or the pharmacy? Fees flowing from the pharmacy to the party sending it orders are the classic shape regulators look at.

None of this is legal advice — consult your own healthcare counsel. But you should know the structure before you sign, because "we take a small percentage" and "the pharmacy covers it" are answers that deserve a lawyer's eyes.

---

What Should I Ask About Provider Approval and Proof?

Ask what specific artifact proves a licensed provider reviewed and approved each order before it reached the pharmacy. You want a retrievable, timestamped record tied to the provider's identity — not a verbal assurance that "a doctor signs off." In an audit, the record is what exists; the assurance is not.

Every compounded or prescription order must be authorized by a licensed provider. That is not a feature to optimize away — it is the legal foundation of the model, and we treat it as exactly that in why provider approval is the gate on every order. The question is not whether the platform claims approval happens; it is whether the platform can hand you the evidence.

Question 5 — Artifact: For any given order, can you show me the exact record that proves provider approval — with a timestamp, the provider's identity, and their credentials — and can I retrieve it myself?

Question 6 — Sequence: Is that approval enforced before the order transmits to the pharmacy, or can an order route without it under any condition?

A platform that treats approval as real can show you the artifact in the demo. Ask them to.

---

What Should I Ask About Fund Holds and Cash Flow?

Ask directly whether the platform can hold, delay, or claw back your funds, and what the maximum reserve is. Reserve clauses and rolling holds buried in a fulfillment or payments agreement can freeze weeks of revenue with little notice. Cash flow is survival for an early operator; a surprise hold has ended businesses.

If a platform sits between you and payment processing, it may have the contractual ability to hold funds against chargebacks, disputes, or "risk." That can be reasonable in moderation and catastrophic when it is open-ended.

Question 7 — Authority: Under what specific conditions can you hold, delay, reserve, or reverse funds owed to me?

Question 8 — Ceiling: What is the maximum reserve percentage and the longest a hold can last? Is it in the contract, or left to your discretion?

Get numbers, not adjectives. "We rarely hold funds" is not a limit.

---

What Should I Ask About Pharmacy Routing and Concentration?

Ask whether you can route orders to more than one pharmacy and whether you can change pharmacies without rebuilding your stack. Single-pharmacy dependency is the most common single point of failure in telehealth fulfillment. If one partner has a backlog, a formulary change, or a compliance event, your entire order flow should not stop.

Multi-pharmacy routing is risk management, not a large-operator luxury — the full argument is in how pharmacy order routing works end to end.

Question 9 — Multiplicity: Can I connect and route to multiple pharmacies, and direct orders by formulary, geography, or capacity?

Question 10 — Portability: If I add or switch a pharmacy, does that happen at the routing layer, or does it require a rip-and-replace of my integration?

A platform locked to one pharmacy is a platform that inherits that pharmacy's every bad day.

---

What Should I Ask About Exit and What Happens If I Leave?

Ask what the notice period is, what you keep, and what offboarding costs. The exit terms are the truest statement of how a platform sees the relationship. A partner confident in its product makes leaving painless; a platform that depends on lock-in makes it expensive.

Question 11 — Terms: What is the notice period to terminate, and are there early-termination or offboarding fees?

Question 12 — Takeaway: On exit, what exactly leaves with me — patient data, order history, provider relationships, active subscriptions — and in what format?

We break down why these costs are so often hidden in the true switching costs of telehealth platform lock-in.

---

The Twelve Questions, Scored

Use this as a one-page scorecard. A good answer is specific and in writing. A bad answer is vague, verbal-only, or "we'll cross that bridge later."

#	Area	The question	Good answer looks like
1–2	Data	Do I own it, and can I export all of it anytime?	Named as system of record; free structured export including history
3–4	Fees	How is the fee calculated, and who pays?	Flat/fixed, value-blind, clinic-paid
5–6	Approval	What artifact proves provider approval, and when?	Retrievable timestamped record, enforced pre-transmission
7–8	Funds	Can you hold my money, and how much/how long?	Narrow, capped, contractual conditions
9–10	Routing	Multi-pharmacy? Switchable without rebuild?	Yes, routable by formulary/geography/capacity
11–12	Exit	Notice, cost, and what leaves with me?	Reasonable notice, no punitive fees, full data out

If a platform scores "good" on data and exit, you can recover from almost any other mistake. If it scores poorly on those two, the rest of the contract barely matters — you are not the owner.

---

How to Actually Run This Diligence

1. Send the twelve questions in writing before the second sales call. Ask for written answers. How a vendor reacts to a written diligence request is itself a signal.
2. Ask to see artifacts, not descriptions. The provider-approval record, a sample data export, the reserve clause in the actual contract.
3. Route the fee and fund-hold answers to your own counsel. Structure is a legal question; do not self-diagnose.
4. Weight the answers. Data ownership and exit are load-bearing. A great demo cannot compensate for failing them.
5. Keep the answers. File the written responses with your contract. If a promise was made verbally and never written down, treat it as not made.

The operators who get burned are almost never the ones who asked too many questions. They are the ones who signed on the strength of the demo and read the exit clause for the first time on the way out.

---

Key Takeaways

• Diligence is about getting verifiable, written answers before money and patients are on the line — not about trusting a good demo.
• Data ownership and export are the master questions: if you cannot leave with your records in a usable format, you do not own your business.
• Fee structure is a compliance question. Flat, value-blind, clinic-paid fees are structurally safer than percentage-of-sale or spread-funded models.
• Ask for the exact artifact that proves provider approval — a timestamped, retrievable record, enforced before the order transmits.
• Fund holds and reserve clauses can freeze cash flow overnight. Get the conditions and the ceiling in the contract.
• Every question should map to a written answer. Silence or hand-waving is the finding.

---

Frequently Asked Questions

What is the most important question to ask a telehealth platform?

Can I export all of my patient and order data in a usable, structured format at any time, at no penalty? Data export is the master question because it determines whether you can ever leave. If the answer is no, unclear, or gated behind fees, every other advantage the platform offers is built on a foundation you do not control. Ask for the export format, the mechanism, and confirmation that it includes historical records — in writing.

Why does the fee structure matter for compliance, not just cost?

Because federal fraud-and-abuse law scrutinizes how healthcare-adjacent fees are calculated. Fees tied to the value or volume of prescriptions, or funded by a spread on the drug itself, invite Anti-Kickback Statute and EKRA questions. Flat, value-blind software fees paid by the clinic for a service are far easier to defend. How your platform charges is a structural risk you inherit. Consult your own counsel — this is educational, not legal advice.

What proof should a platform give that a provider approved an order?

A retrievable, timestamped record tied to a licensed provider's identity and credentials, generated before the order transmits to the pharmacy. Ask to see the actual artifact — a review record, approval log, or certificate — not a description of one. If provider approval is real, the platform can show you exactly where it is recorded and how you retrieve it during an audit.

Can a fulfillment platform hold my funds?

Some can, through reserve clauses, rolling holds, or by sitting between you and payment processing. A hold you did not anticipate can freeze weeks of revenue overnight. Before signing, ask directly: under what conditions can you hold, delay, or claw back funds, and what is the maximum reserve? Get the answer in the contract, not a sales call.

What should I ask about leaving the platform?

Ask three things: what is the notice period, what do I keep, and what does offboarding cost? A fair platform lets you leave with your patient data, order history, and provider relationships intact, on reasonable notice, without punitive fees. If exit terms are vague or the data comes with you only in a locked format, the switching cost is the real price of the contract.

---

neolife is built to pass its own checklist: you are the system of record, your data exports on demand, fees are flat and clinic-paid, every order carries a retrievable provider-approval record, and you route across pharmacies without a rip-and-replace. If you are evaluating fulfillment infrastructure and want straight answers to all twelve questions, talk to us. This post is educational and not legal or medical advice — verify specifics with your own compliance counsel.